Sotuletinib (BLZ945) is an orally bioavailable inhibitor of colony-stimulating factor 1 receptor (CSF-1R). It selectively binds to CSF-1R on tumor-associated macrophages, blocking receptor activity and modulating immune signaling in the tumor microenvironment.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing BLZ945?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Omeprazole magnesium
pharmaceutical raw material
Omeprazole sodium
pharmaceutical raw material
Adavosertib
pharmaceutical raw material
4-Hydroxy-2,2-diphenylbutyric acid gamma-lactone
pharmaceutical raw material
The international HS code for BLZ945 (CAS 953769-46-5) is 2934.20.
2934.20
2934 20 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide
ADZBMFGQQWPHMJ-RHSMWYFYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)N[C@@H]4CCCC[C@H]4O
Sourcing BLZ945?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.